Computational models for analyzing lipoprotein profiles

Clinical Lipidology

Volumn 6, Issue 1, 2011, Pages 25-33

  De Graaf, Albert A ^a   Van Schalkwijk, Daniël B ^a  

^a TNO   (Netherlands)

Author keywords

cardiovascular disease; cholesterol; computational modeling; diabetes; diagnostic biomarkers; HDL; hyperlipidemia; LDL; lipoprotein; triglyceride

Indexed keywords

BIOLOGICAL MARKER; CHYLOMICRON; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ARTICLE; CARDIOVASCULAR DISEASE; DATA ANALYSIS; DIABETES MELLITUS; DIAGNOSTIC VALUE; DYSLIPIDEMIA; FAST PROTEIN LIQUID CHROMATOGRAPHY; FIELD FLOW FRACTIONATION; GEL PERMEATION CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; ION MOBILITY SPECTROMETRY; LIPID TRANSPORT; LIPOPROTEIN ANALYSIS; LIPOPROTEIN METABOLISM; MATHEMATICAL MODEL; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PARTICLE SIZE; PREDICTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; RISK ASSESSMENT; STATISTICAL MODEL; ULTRACENTRIFUGATION;

EID: 79951494456     PISSN: 17460875     EISSN: None     Source Type: Journal    
DOI: 10.2217/clp.10.85     Document Type: Article

References (59)

1. Brewer J, Gregg RE, Hoeg JM, Fojo SS: Apolipoproteins and lipoproteins in human plasma: an overview. Clin. Chem. 34(8 Suppl. B), B4-B8 (1988).
2. Burnett JR, Hugh P, Barrett R: Apolipoprotein B metabolism: tracer kinetics, models, and metabolic studies. Crit. Revs. Clin. Lab. Sci. 39(2), 89-137 (2002). (Pubitemid 34492990)
3. Rashid S, Patterson BW, Lewis GF: What have we learned about HDL metabolism from kinetics studies in humans? J. Lipid Res. 47(8), 1631-1642 (2006). (Pubitemid 44222815)
4. Williams KJ: Molecular processes that handle -and mishandle -dietary lipids. J. Clin. Invest. 118(10), 3247-3259 (2008).
5. Noto HM: Latest insights into high-density lipoprotein functions. Endocrinologist 19(4), 179-186 (2009).
6. Grundy SM, Cleeman JI, Merz CN et al.: Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 110(2), 227-239 (2004). (Pubitemid 38924592)
7. Brunzell JD, Davidson M, Furberg CD et al.: Lipoprotein management in patients with cardiometabolic risk: consensus conference report from the American Diabetes Association and the American College of Cardiology Foundation. J. Am. Coll. Cardiol. 51(15), 1512-1524 (2008). (Pubitemid 351470037)
8. Hajer GR, Van Der Graaf Y, Bots ML, Algra A, Visseren FLJ: Low plasma HDL-C, a vascular risk factor in high risk patients independent of LDL-C. Eur. J. Clin. Invest. 39(8), 680-688 (2009).
9. Austin MA, King MC, Vranizan KM, Krauss RM: Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. Circulation 82(2), 495-506 (1990). (Pubitemid 20257828)
10. Otvos JD, Jeyarajah EJ, Bennett DW, Krauss RM: Development of a proton nuclear magnetic resonance spectroscopic method for determining plasma lipoprotein concentrations and subspecies distributions from a single, rapid measurement. Clin. Chem. 38(9), 1632-1638 (1992).
11. Usui S, Hara Y, Hosaki S, Okazaki M: A new on-line dual enzymatic method for simultaneous quantifcation of cholesterol and triglycerides in lipoproteins by HPLC. J. Lipid Res. 43(5), 805-814 (2002). (Pubitemid 34477908)
12. Rambaldi DC, Zattoni A, Casolari S, Reschiglian P, Roessner D, Johann C: An analytical method for size and shape characterization of blood lipoproteins. Clin. Chem. 53(11), 2026-2029 (2007). (Pubitemid 350036063)
13. Caulfeld MP, Li S, Lee G et al.: Direct determination of lipoprotein particle sizes and concentrations by ion mobility analysis. Clin. Chem. 54(8), 1307-1316 (2008).
14. Caulfeld MP, Li S, Lee G et al.: In reply. Clin. Chem. 54(12), 2088-2089 (2008). (Pubitemid 352774053)
15. Rizzo M, Berneis K: Should we measure routinely the LDL peak particle size? Int. J. Cardiol. 107(2), 166-170 (2006).
16. Cromwell WC, Otvos JD, Keyes MJ et al.: LDL particle number and risk of future cardiovascular disease in the Framingham Offspring Study -implications for LDL management. J. Clin. Lipidol. 1(6), 583-592 (2007). (Pubitemid 350215511)
17. Mora S, Otvos JD, Rifai N, Rosenson RS, Buring JE, Ridker PM: Lipoprotein particle profles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women. Circulation 119(7), 931-939 (2009).
18. Arsenault BJ, Rana JS, Stroes ESG et al.: Beyond low-density lipoprotein cholesterol: respective contributions of non-high-density lipoprotein cholesterol levels, triglycerides, and the total cholesterol/high-density lipoprotein cholesterol ratio to coronary heart disease risk in apparently healthy men and women. J. Am. Coll. Cardiol. 55(1), 35-41 (2009).
19. Havel RJ, Eder HA, Bragdon JH: The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 34(9), 1345-1353 (1955).
20. Wilcox HG, Davis DC, Heimberg M: The isolation of lipoproteins from human plasma by ultracentrifugation in zonal rotors. J. Lipid Res. 12(2), 160-172 (1971).
21. Lindgren FT, Freeman NK, Ewing AM, Jensen LC: Serum lipoprotein distribution, fotation rates and protein analysis. J. Am. Oil Chem. Soc. 43(5), 281-285 (1966).
22. Yee MS, Pavitt DV, Tan T et al.: Lipoprotein separation in a novel iodixanol density gradient, for composition, density, and phenotype analysis. J. Lipid Res. 49(6), 1364-1371 (2008).
23. Jeyarajah EJ, Cromwell WC, Otvos JD: Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy. Clin. Lab. Med. 26(4), 847-870 (2006). (Pubitemid 44716510)
24. Ala-Korpela M, Lankinen N, Salminen A et al.: The inherent accuracy of 1H NMR spectroscopy to quantify plasma lipoproteins is subclass dependent. Atherosclerosis 190(2), 352-358 (2007). (Pubitemid 46074051)
25. Parhofer KG, Barrett PH: What we have learned about VLDL and LDL metabolism from human kinetic studies. J. Lipid Res. 47, 1620-1630 (2006). (Pubitemid 44222814)
26. Patterson BW, Mittendorfer B, Elias N, Satyanarayana R, Klein S: Use of stable isotopically labeled tracers to measure very low density lipoprotein-triglyceride turnover. J. Lipid Res. 43(2), 223-233 (2002). (Pubitemid 34184009)
27. Packard CJ, Gaw A, Demant T, Shepherd J: Development and application of a multicompartmental model to study very low density lipoprotein subfraction metabolism. J. Lipid Res. 36(1), 172-187 (1995).
28. Adiels M, Packard C, Caslake MJ et al.: A new combined multicompartmental model for apolipoprotein B-100 and triglyceride metabolism in VLDL subfractions. J. Lipid Res. 46(1), 58-67 (2005). (Pubitemid 40066671)
29. de Graaf AA, Freidig AP, De Roos B et al.: Nutritional systems biology modeling: from molecular mechanisms to physiology. PLoS Comput. Biol. 5(11), E1000554 (2009).
30. Pappalardo F, Musumeci S, Motta S: Modeling immune system control of atherogenesis. Bioinformatics 24(15), 1715-1721 (2008).
31. Davidson MH, Toth PP: Comparative effects of lipid-lowering therapies. Progr. Cardiovasc. Dis. 47(2), 73-104 (2004) 32 August E, Parker KH, Barahona M: A dynamical model of lipoprotein metabolism. Bull. Math. Biol. 69(4), 1233-1254 (2007).
32. Tindall MJ, Wattis JA, O'Malley BJ, Pickersgill L, Jackson KG: A continuum receptor model of hepatic lipoprotein metabolism. J. Theor. Biol. 257(3), 371-384 (2009).
33. Pearson T, Wattis JA, O'Malley B et al.: Mathematical modelling of competitive LDL/VLDL binding and uptake by hepatocytes. J. Math. Biol. 58, 845-880 (2009).
34. van de Pas NC, Soffers AE, Freidig AP et al.: Systematic construction of a conceptual minimal model of plasma cholesterol levels based on knockout mouse phenotypes. Biochim. Biophys. Acta 1801(6), 646-654 (2010).
35. Eppig JT, Blake JA, Bult CJ, Kadin JA, Richardson JE: The mouse genome database (MGD): new features facilitating a model system. Nucleic Acids Res. 35(Suppl. 1), D630-D637 (2007). (Pubitemid 46056282)
36. van Schalkwijk DB, van Bochove K, van Ommen B et al.: Developing computational model-based diagnostics to analyse clinical chemistry data. Brief Bioinform. 11(4), 403-416 (2010).
37. Hübner K, Schwager T, Winkler K, Reich JG, Holzhutter HG: Computational lipidology: predicting lipoprotein density profles in human blood plasma. PLoS Comput. Biol. 4(5), E1000079 (2008).
38. van Schalkwijk DB, de Graaf AA, van Ommen B et al.: Improved cholesterol phenotype analysis by a model relating lipoprotein life cycle processes to particle size. J. Lipid Res. 50(12), 2398-2411 (2009).
39. van Schalkwijk DB, van Ommen B, Freidig AA, van der Greef J, de Graaf AA: MS547 introducing the VLDL performance diagnostic. Atheroscl. Suppl. 11(2), 220-220 (2010).
40. Bloomgarden ZT: 2009 World Congress on the Insulin Resistance Syndrome: Cardiovascular Disease Concepts. Diabetes Care 33(7), E85-E89 (2010).
41. Musunuru K, Orho-Melander M, Caulfeld MP et al.: Ion mobility analysis of lipoprotein subfractions identifes three independent axes of cardiovascular risk. Arterioscler. Thromb. Vasc. Biol. 29(11), 1975-1980 (2009).
42. Suna T, Salminen A, Soininen P et al.: 1H NMR metabonomics of plasma lipoprotein subclasses: elucidation of metabolic clustering by self-organising maps. NMR Biomed. 20(7), 658-672 (2007). (Pubitemid 350120246)
43. Kumpula LS, Makela SM, Makinen VP et al.: Characterization of metabolic interrelationships and in silico phenotyping of lipoprotein particles using self-organizing maps. J. Lipid Res. 51(2), 431-439 (2010).
44. van Schalkwijk DB, van Bochove K, Parnell LD et al.: MS327 clustering by plasma lipoprotein profle reveals large fenofbrate responder subgroup. Atheroscl. Suppl. 11(2), 175-175 (2010).
45. Pencina MJ, DAgostino RB Sr, DAgostino RB Jr, Vasan RS: Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassifcation and beyond. Stat. Med. 27(2), 157-172 (2008). (Pubitemid 351193639)
46. Sacks FM, Campos H: Clinical review 163: Cardiovascular endocrinology: low-density lipoprotein size and cardiovascular disease: a reappraisal. J. Clin. Endocrinol. Metab. 88(10), 4525-4532 (2003). (Pubitemid 37357487)
47. Nambi V, Hoogeveen RC, Chambless L et al.: Lipoprotein-associated phospholipase A and 2 high-sensitivity C-reactive protein improve the stratifcation of ischemic stroke risk in the Atherosclerosis Risk in Communities (ARIC) study. Stroke 40(2), 376-381 (2009).
48. Mora S, Otvos JD, Rosenson RS, Pradhan A, Buring JE, Ridker PM: Lipoprotein particle size and concentration by nuclear magnetic resonance and incident Type 2 diabetes in women. Diabetes 59(5), 1153-1160 (2010).
49. Mora S, Kamstrup PR, Rifai N, Nordestgaard BG, Buring JE, Ridker PM: Lipoprotein (a) and risk of Type 2 diabetes. Clin. Chem. 56(8), 1252-1260 (2010).
50. Okazaki M, Usui S, Ishigami M et al.: Identifcation of unique lipoprotein subclasses for visceral obesity by component analysis of cholesterol profle in high-performance liquid chromatography. Arterioscler. Thromb. Vasc. Biol. 25(3), 578-584 (2005). (Pubitemid 40315681)
51. Otvos JD: Measurement of lipoprotein subclass profles by nuclear magnetic resonance spectroscopy. Clin. Lab. 48(3-4), 171-180 (2002). (Pubitemid 34272531)
52. Freedman DS, Otvos JD, Jeyarajah EJ et al.: Sex and age differences in lipoprotein subclasses measured by nuclear magnetic resonance spectroscopy: the Framingham study. Clin. Chem. 50(7), 1189-1200 (2004). (Pubitemid 38824227)
53. Festa A, Williams K, Hanley AJG et al.: Nuclear magnetic resonance lipoprotein abnormalities in prediabetic subjects in the insulin resistance atherosclerosis study. Circulation 111(25), 3465-3472 (2005). (Pubitemid 40923401)
54. Otvos JD, Jeyarajah EJ, Cromwell WC: Measurement issues related to lipoprotein heterogeneity. Am. J. Cardiol. 90(8A), I22-I29 (2002).
55. Van Gent T, Van Tol A: Automated gel permeation chromatography of plasma lipoproteins by preparative fast protein liquid chromatography. J. Chromatogr. 525(2), 433-441 (1990). (Pubitemid 20058973)
56. Marz W, Siekmeier R, Scharnagl H, Seiffert UB, Gross W: Fast lipoprotein chromatography: new method of analysis for plasma lipoproteins. Clin. Chem. 39(11 Pt 1), 2276-2281 (1993). (Pubitemid 23333319)
57. Rambaldi DC, Reschiglian P, Zattoni A, Johann C: Enzymatic determination of cholesterol and triglycerides in serum lipoprotein profles by asymmetrical fow feld-fow fractionation with on-line, dual detection. Anal. Chim. Acta 654(1), 64-70 (2009).
58. Sata T, Havel RJ, Jones AL: Characterization of subfractions of triglyceride-rich lipoproteins separated by gel chromatography from blood plasma of normolipemic and hyperlipemic humans. J. Lipid Res. 13(6), 757-768 (1972).
59. Tadey T, Purdy WC: Chromatographic techniques for the isolation and purifcation of lipoproteins. J. Chromatogr. B Biomed. Appl. 671(1-2), 237-253 (1995).